Lewis Gruber is a serial biotech entrepreneur. He brings over 35 years of biotechnology management experience and success to his role as CEO and Chief Scientific Officer of SIWA Therapeutics, having previously founded and sold two breakthrough biotechnology companies. He founded and led Arryx, Inc. which was recognized as a World Economic Forum Technology Pioneer as well as a Red Herring Top 100 Innovator. Gruber also founded and led Hyseq, Inc. and completed the largest initial public offering of a biotechnology company in 1997. In addition, he negotiated commercial partnerships for Hyseq that generated more than $100 million.